Clinical Trial

The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2024 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the effect of a probiotic supplement containing Bifidobacterium animalis lactis BL-04 on the clinical effectiveness of immunotherapy in patients diagnosed with metastatic non-small cell lung cancer who are receiving immunotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-20.
Status change: Not Yet Recruiting → Recruiting 2024-08-14
Trial Details
NCT Number NCT06428422
Lead Sponsor Necmettin Erbakan University
Collaborators: Health Institutes of Turkey
Conditions Metastatic Non-small Cell Lung Cancer
Enrollment 100 participants
Start Date 2024-08-12
Primary Completion 2025-10-31 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2024-08-16